STAT

Opinion: Microhospitals and healthplexes offer a peek at the future of health care

Smaller may trump larger when it comes to better, less expensive health care.

The once insular health care industry now finds itself facing the fallout from decades spent resisting change: an all-sides blitz orchestrated by outsiders intent on doing the changing for it. Besieged by upstarts and titans alike, even the most change-averse organizations are being forced to adapt to this threat. For leaders already laying foundations for innovation within the industry, these disruptions are providing new platforms on which to build the health care delivery models of the future.

Hospitals have long been the exemplar of the old-school model, where bigger is better, evolution is met with suspicion, and more services — regardless of their necessity — mean more lucrative kickbacks from the regulators in charge. As hospitals cling to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks